Ingevity (NGVT) Liabilities and Shareholders Equity (2015 - 2026)

Ingevity (NGVT) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 18.12% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $6.7 billion (down 18.31% YoY), while the FY2025 annual figure was $1.7 billion, down 18.37% from the prior year.
• Liabilities and Shareholders Equity slipped to $1.5 billion in Q2 2026 per NGVT's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.8 billion in Q2 2023 and bottomed at $1.5 billion in Q2 2026.
• Historically, Liabilities and Shareholders Equity has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2022.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity increased 19.54% — and 2024, when it retreated 22.9%.
• Ingevity's Liabilities and Shareholders Equity stood at $2.7 billion in 2022, then declined by 4.14% to $2.6 billion in 2023, then declined by 22.9% to $2.0 billion in 2024, then retreated by 18.37% to $1.7 billion in 2025, then slipped by 6.88% to $1.5 billion in 2026.
• Business Quant data shows NGVT's Liabilities and Shareholders Equity at $1.5 billion in Q2 2026, $1.7 billion in Q1 2026, and $1.7 billion in Q4 2025.